Weiss Lawrence T
Weiss Lawrence T's purchase track record
Weiss Lawrence T has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 10/21/2025 | ANGO | $118K | -11.5% | -8.4% | +4.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Butterfly Network Announces Long‑Term Alliance with VCOM and Gains New Coverage. Butterfly Network entered a long‑term partnership with the Edward Via College of Osteopathic Medicine to develop a new ultrasound education model. The collaboration aims to expand training tools for medical students. In addition, Canaccord Genuity started coverage on the stock, setting a price target of $10. The move reflects growing interest in Butterfly’s technology and its educational applications.
Transaction History
| ANGO | ▼ Sell | Tax Withholding | 2,267 | $32K | 7/16/2026 | View on chart |
| ANGO | ▲ Buy | Grant | 21,288 | $0 | 7/15/2026 | View on chart |
| ANGO | ▲ Buy | Open Market | 10,000 | $118K | 10/21/2025 | View on chart |
| ANGO | ▲ Buy | Grant | 30,900 | $0 | 7/16/2025 | View on chart |
| ANGO | ▲ Buy | Grant | 52,697 | $0 | 12/2/2024 | View on chart |
| BFLY | ▼ Sell | Open Market | 27,655 | $61K | 7/5/2023 | View on chart |
| BFLY | ▼ Sell | Open Market | 52,296 | $116K | 5/24/2023 | View on chart |
| BFLY | ▲ Buy | Grant | 174,000 | $0 | 3/1/2023 | View on chart |
| BFLY | ▲ Buy | Grant | 452,000 | $0 | 3/1/2023 | View on chart |
| BFLY | ▲ Buy | Grant | 690,789 | $0 | 5/23/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
ANGO Announces Q1 Fiscal 2027 Results Date
AngioDynamics (ANGO) will report its fiscal 2027 first‑quarter earnings on Oct. 8, 2026. The earnings release will provide updated guidance on revenue, operating income and cash flow for the quarter. Analysts will review the results to assess the company’s performance against expectations. The announcement is the main event for the stock this week.
ANGO Announces Q1 Fiscal 2027 Results Date. AngioDynamics (ANGO) will report its fiscal 2027 first‑quarter earnings on Oct. 8, 2026. The earnings release will provide updated guidance on revenue, operating income and cash flow for the quarter. Analysts will review the results to assess the company’s performance against expectations. The announcement is the main event for the stock this week.